Testing for COVID-19 is technical, expensive and complicated -- particularly in Alaska, with its remote, far-flung communities and overlapping systems of tribal and private health care. That ...
SUNNYVALE, Calif., June 9, 2020 /PRNewswire/ -- Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the ...
For much of last year, the coronavirus crept, undetected, across eastern Democratic Republic of Congo. Test samples had to be sent more than 1,500 kilometres from remote hospitals to the capital ...
SUNNYVALE, Calif., Sept. 29, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress ...
Health Canada has granted a medical device licence for Cepheid’s Xpert HCV VL Fingerstick, a test used to detect and quantify the hepatitis C virus (HCV) from a single blood drop. This advancement is ...
Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season SUNNYVALE, Calif., Jan. 14, 2021 /CNW/ -- Cepheid today ...
The U.S. Food and Drug Administration (FDA) is moving much more quickly to grant special ’emergency use authorization’ to equipment and tests that could help increase testing for the novel coronavirus ...
The Abbott coronavirus test hailed by President Trump and used by the White House failed to detect infected samples in a large number of cases that were caught by a rival firm, a preliminary study has ...